Valuation: China Isotope & Radiation Corporation

Market Cap 4.7B 5.45B 695M 608M 562M 517M 977M 67.02B 994M 6.72B 2.63B 32.74B 2.61B 2.55B 113B P/E 2024
8.03x
P/E 2025 17.7x
Enterprise Value 4.82B 5.59B 713M 623M 576M 530M 1B 68.72B 1.02B 6.89B 2.7B 33.57B 2.68B 2.62B 116B EV / Sales 2024
0.42x
EV / Sales 2025 0.82x
Free-Float
91.21%
Yield 2024
3.74%
Yield 2025 1.69%
Jul. 05 China Isotope to Form JV With Associate MT
Jul. 03 China Isotope & Radiation Corporation and CNNC Yuanke Enter into Shareholders? Agreement to Establish Joint Venture Company CNNC Fuyuan CI
Jun. 18 China Isotope & Radiation Corporation Approves Final Dividend for the Year Ended 31 December 2025, Payable on Before 17 August 2026 CI
Jun. 18 China Isotope & Radiation Corporation Appoints Zhang Guoliang as A Member of Legal Affairs Committee of the Board and A Member of Science and Technology Innovation Committee of the Board CI
May. 26 China Isotope Proposes Auditor Change MT
May. 26 China Isotope & Radiation Corporation Announces Ma Xiaoyu Resignation of Ma Xiaoyu as an Executive Director Member of the Legal Affairs Committee Science and Technology Innovation Committee, Effective May 26, 2026 CI
Mar. 27 China Isotope & Radiation final cash dividend of RMB0.2264 per share RE
Mar. 27 China Isotope & Radiation Corporation Proposes Final Dividend for the Year Ended December 31, 2025, Payable Before 17 August 2026 CI
Mar. 27 China Isotope & Radiation Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 CI
Mar. 19 China Isotope & Radiation to buy 51% stake in Hunan Huifeng Engineering Detection RE
Mar. 13 China Isotope & Radiation Corporation, Zhonghe Headway and the People?s Government of Maoming Municipality Enter Strategic Cooperation Agreement CI
Mar. 13 China Isotope & Radiation says co and Zhonghe Headway enter strategic cooperation agreement with Maoming municipality RE
Mar. 02 China Isotope & Radiation's Unit Gets China Nod for Market Launch of Breath Analyzer MT
1 day+1.19%
1 week-0.29%
Current month-2.86%
1 month-12.55%
3 months-6.08%
6 months-23.08%
Current year-15.84%
1 week 16.62
Extreme 16.62
17.79
1 month 16.5
Extreme 16.5
19.99
Current year 16.5
Extreme 16.5
24.28
1 year 15
Extreme 15
25
3 years 9.03
Extreme 9.03
25
5 years 9.03
Extreme 9.03
30.3
10 years 9.03
Extreme 9.03
35.4
Manager TitleAgeSince
Chief Executive Officer 55 2024-08-01
Corporate Secretary - 2024-08-29
Corporate Secretary - 2024-08-29
Director TitleAgeSince
Director/Board Member 57 2017-02-21
Director/Board Member 54 2019-06-27
Director/Board Member 54 2019-12-29
Change 5-day change 1-year change 3-year change Capi.($)
+1.19%-0.29%+9.11%+25.74% 685M
-5.00%-7.49%+218.70%+290.38% 20.67B
-1.10%+3.44%-39.02%-23.29% 9.85B
-2.96%-1.17%+48.76%+17.03% 7B
-1.19%+1.15%+255.72%-28.12% 5.55B
+3.43%+7.18%-14.36%-20.83% 5.23B
-8.46%+23.30%+84.85%+105.62% 4.9B
-5.64%-8.42%-48.46% - 4.66B
+1.27%+2.01%-22.43%-25.26% 4.2B
+1.21%+5.98%-14.81%-39.11% 2.72B
Average -1.72%+3.12%+47.81%+33.57% 6.55B
Weighted average by Cap. -2.78%+2.19%+89.85%+97.81%

Financials

2024 2025
Net sales 7.57B 8.79B 1.12B 980M 906M 833M 1.58B 108B 1.6B 10.84B 4.24B 52.81B 4.21B 4.12B 182B 7.19B 8.34B 1.06B 930M 860M 791M 1.49B 103B 1.52B 10.28B 4.03B 50.11B 3.99B 3.91B 173B
Net income 407M 472M 60.18M 52.63M 48.66M 44.73M 84.57M 5.8B 86.03M 582M 228M 2.84B 226M 221M 9.78B 327M 380M 48.45M 42.38M 39.18M 36.01M 68.1M 4.67B 69.27M 468M 183M 2.28B 182M 178M 7.87B
Net Debt -109M -126M -16.12M -14.1M -13.04M -11.98M -22.66M -1.55B -23.05M -156M -61.02M -759M -60.53M -59.21M -2.62B 119M 138M 17.59M 15.38M 14.22M 13.07M 24.72M 1.7B 25.14M 170M 66.57M 829M 66.04M 64.59M 2.86B
Logo China Isotope & Radiation Corporation
China Isotope & Radiation Corp is a China-based company mainly engaged in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products. The Company operates five business segments. Pharmaceuticals segment is engaged in providing imaging diagnostic and therapeutic radiopharmaceuticals, urea breath test (UBT) kits and analyzers and in vitro diagnostic reagents and kits. Radioactive Source Products segment is engaged in providing various medical and industrial radioactive sources products as well as provision of related technical services. Irradiation segment is engaged in providing sterilization services. Radiation Therapy Equipment and Related Services segment is engaged in manufacturing Radiation therapy equipment. Other Businesses segment is engaged in providing trade services in relation to imported radioactive source, medical nuclides, imported radiopharmaceuticals, and other products.
Employees
3,578
Date Price Change Volume
26-07-20 HK$17.00 +1.19% 36,400
26-07-17 HK$16.80 -4.49% 294,400
26-07-16 HK$17.59 +3.17% 107,600
26-07-15 HK$17.05 +2.10% 61,800
26-07-14 HK$16.70 +1.21% 93,400

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1763 Stock